Holding(s) in the Company
Faron Pharmaceuticals Oy ("Faron" or the "Company") Holding(s) in the Company Company announcement, 17 February 2021 at 3.40pm GMT / 5.40pm EET TURKU – FINLAND – Faron Pharmaceuticals Oy (First North: FARON, AIM: FARN), the clinical stage biopharmaceutical company, has on 16 February 2021 received notifications from Mr. Timo Syrjälä and Mr. Tom-Erik Lind of the decrease of their holdings due to issuance of new shares. Trading in the Placing Shares commenced on First North and AIM on 16 February 2021. The mentioned notifications are attached in this announcement. For